Ignite Creation Date:
2024-05-06 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 12:52 PM
Study NCT ID:
NCT03643549
Status:
RECRUITING
Last Update Posted:
2024-02-29
First Post:
2018-08-21
Brief Title:
Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter BORTEM-17
Sponsor:
Organization:
Haukeland University Hospital